Core Viewpoint - Guizhou Sanli Pharmaceutical Co., Ltd. has successfully passed a board resolution to sign a technology transfer contract with Hainan University, marking a significant step in the company's strategic layout in technological innovation [1] Group 1: Board Meeting Details - The fourth board meeting was held on December 22, 2025, with all nine directors present, and the resolution was passed unanimously [1] - The technology transfer contract was previously reviewed and approved by the company's Strategic Committee [1] Group 2: Implications of the Technology Transfer - The technology transfer is expected to have a potential impact on the company's product line expansion and enhancement of core competitiveness [1] - The specific details of the technology transfer contract will be disclosed in a separate announcement [1]